[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Pages 57493-57494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23316]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2016-0122]


Program-Specific Guidance About Medical Use Licenses

AGENCY: Nuclear Regulatory Commission.

ACTION: NUREG; issuance.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has issued 
Revision 3 to NUREG-1556, Volume 9, ``Consolidated Guidance About 
Materials Licenses: Program-Specific Guidance About Medical Use 
Licenses.'' NUREG-1556 Volume 9 has been revised to include information 
on updated regulatory requirements, safety culture, security of 
radioactive materials, protection of sensitive information, and changes 
in regulatory policies and practices consistent with current 
regulations. This volume is intended for use by applicants, licensees, 
and the NRC staff.

DATES:  NUREG 1556, Volume 9, Revision 3, was published in September 
2019.

ADDRESSES: Please refer to Docket ID NRC 2016-0122 (NUREG-1556, Vol. 9, 
Rev. 3), when contacting the NRC about the availability of information 
regarding this document. You may obtain publicly-available information 
related to this document using any of the following methods:
     Federal Rulemaking Website: Go to http://www.regulations.gov and search for Docket ID NRC-2016-0122. Address 
questions about NRC dockets to Jennifer Borges; telephone: 301-287-
9127; email: [email protected]. For technical questions, contact 
the individual listed in the FOR FURTHER INFORMATION CONTACT section of 
this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. 
NUREG-1556, Volumes 9, Revision 3, is located at ADAMS Accession No. 
ML19256C219. This document is also available on the NRC's public 
website at http://www.nrc.gov/reading-rm/doc-collections/nuregs/staff/sr1556/ under ``Consolidated Guidance About Materials Licenses (NUREG-
1556).''
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Dr. Katherine Tapp, Office of Nuclear 
Material Safety and Safeguards; U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001; telephone: 301-415-0236; email: 
[email protected].

SUPPLEMENTARY INFORMATION: 

I. Discussion

    The NRC issued a revision to NUREG-1556, Volumes 9, to provide 
guidance to existing materials licensees covered under medical use 
licenses and to applicants preparing an application for a medical use 
license of byproduct material. This NUREG volume also provides the NRC 
staff with criteria for evaluating medical use license applications. 
The purpose of this notice is to notify the public that the NUREG-1556 
volume listed in this document was issued as a final report.

II. Additional Information

    The NRC published a notice of the availability of the draft report 
for comment version of NUREG-1556, Volume 9, Revision 3 in the Federal 
Register on December 6, 2016 (81 FR 87978), with an original public 
comment period of 63 days. The public comment period was extended for 
an additional 53 days on January 26, 2017 (82 FR 8545). The public 
comment period closed on March 31, 2017. Public comments and the NRC 
staff responses to the public comments for NUREG-1556, Volume 9, 
Revision 3 are available under ADAMS Accession No. ML18327A102.

III. Congressional Review Act

    This NUREG volume is a rule as defined in the Congressional Review

[[Page 57494]]

Act (5 U.S.C. 801-808). However, the Office of Management and Budget 
has not found this NUREG revision to be a major rule as defined in the 
Congressional Review Act.

    Dated at Rockville, Maryland, this 21st day of October 2019.

    For the Nuclear Regulatory Commission.
Michael C. Layton,
Director, Division of Materials Safety, Security, State and Tribal 
Programs, Office of Nuclear Material Safety and Safeguards.
[FR Doc. 2019-23316 Filed 10-24-19; 8:45 am]
 BILLING CODE 7590-01-P